EFTA00707641Set 9
2017-09-1024p6,911w
insulin
insensitivity), reduced dopaminergic
signaling, reduced serotonergic
signaling, reduced cholinergic
signaling, or reduced GABAergic
signaling, and include Alzheimer's
disease, Parkinson's disease, epilepsy,
neuropathic pain, fibromyalgia, post-
herpetic neuralgia
https://www.justice.gov/epstein/files/DataSet%209/EFTA00707641.pdf